More direct evidence that FHR proteins drive complement activation in AMD came from the discovery that increased circulating concentrations of FHR-4 in AMD-affected individuals are driven by known CFH-locus AMD-risk variants.24 The gene discussed is CFHR4; the disease is age-related macular degeneration.